13 Cheap Stocks to Buy For the Next 5 Years

2. Bristol-Myers Squibb Company (NYSE:BMY)

Forward P/E Ratio as of October 7: 7.58

EPS Forward Long Term Growth (3-5 Year CAGR): 59.65%

Number of Hedge Fund Holders: 67

Bristol-Myers Squibb Company (NYSE:BMY)  is one of the cheap stocks to buy for the next 5 years. On October 2, Bristol Myers Squibb announced a development in its Alzheimer’s program: its experimental drug, BMS-986446, received Fast Track designation from the US FDA.

The designation expedites the review process for the drug, which is currently in Phase 2 testing for patients in the early stages of Alzheimer’s disease. In preclinical studies, the drug demonstrated a sharp reduction in tau uptake and spread, and protected against behavioral decline. The Fast Track status gives Bristol Myers Squibb an advantage in the competitive field of Alzheimer’s treatments.

The therapy targets the tau protein, which spreads in the brains of Alzheimer’s patients. By neutralizing this spread and promoting the clearance of pathological tau, BMS-986446 modifies the underlying course of the disease with the goal of slowing or delaying disease progression.

Bristol-Myers Squibb Company (NYSE:BMY) discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.